Tirzepatide May Not Increase Risk of Depression or Suicidal Ideation

from TheBrief.Health · host TheBrief.Health

Tirzepatide shows no increased risk of depression or suicidal thoughts in trials, supporting its psychological safety and giving clinicians greater confidence when prescribing weight management therapy.

Episode metadata supplied by the publisher feed · Published Apr 22, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Tirzepatide May Not Increase Risk of Depression or Suicidal Ideation

0:00 1:01

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on April 22, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!